CD8A and neoplasm: ,28 In fact, mice undergoing anti-PD-L1 with Bifidobacterium supplementation have demonstrated an improved antitumor T cell response through enhanced tumor control, stimulation of tumor-specific T cells, and increase in antigen-specific CD8+ T cells within the tumor compared with non-Bifidobacterium-treated mice.27